市場調查報告書
商品編碼
1370477
多毛症市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Hirsutism Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球多毛症市場規模達28億美元。展望未來,IMARC Group預計到2028年市場規模將達到43億美元,2023-2028年年複合成長率(CAGR)為7.2%。
多毛症是一種影響女性的疾病,會導致特定身體部位的毛髮過度生長,包括臉部、頸部、胸部、腹部、下背部和大腿。它通常是由於雄性激素(稱為雄激素)過多和某些醫療狀況(例如多囊性卵巢綜合症(PCOS))造成的。多毛症可以透過藥物、局部除毛產品或透過電解、雷射療法和除毛設備等手術來治療。禿頭、痤瘡、聲音低沉、髮際線後退、乳房縮小和肌肉質量增加是多毛症的一些常見症狀。
全球多毛症病例數量的不斷增加,尤其是老年女性,正在為市場創造積極的前景。多毛症通常發生在停經後婦女身上,由腎上腺或卵巢腫瘤分泌雄性激素所致。此外,由於女性體毛過多而導致身體疾病的發生率上升,可能會導致美容和心理問題,這反過來又有利於市場的成長。此外,醫療保健專業人員和活動人士正在向大眾宣傳多毛症的可用治療方法,這是另一個生長誘導因素。除此之外,對需要多次治療的雷射和強烈脈衝光(IPL)設備除毛手術的需求不斷增加,這也推動了市場的成長。與此一致,製造商正在專注於開發基於二甲雙胍的外用療法,作為多囊性卵巢症候群女性中度至重度多毛症的有效治療方法,這正在推動市場成長。此外,由於職業女性人口不斷成長,個人護理支出不斷增加,對市場成長產生了積極影響。其他因素,包括廣泛的研發 (R&D) 活動、雷射除毛技術的接受度不斷提高以及 PCOS 的日益流行,預計將推動市場成長。
The global hirsutism market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028.
Hirsutism is a condition affecting females that cause excess hair growth on specific body parts, including the face, neck, chest, stomach, lower back, and thighs. It commonly occurs due to excess male hormones, called androgens, and certain medical conditions, such as polycystic ovary syndrome (PCOS). Hirsutism can be treated with medication, topical hair removal products, or through procedures, such as electrolysis, laser therapy, and hair removal equipment. Balding, acne, deepening voice, receding hairline, decreased breast size, and increased muscle mass are some common symptoms of hirsutism.
The increasing number of hirsutism cases, especially in older women, across the globe is creating a positive outlook for the market. Hirsutism commonly occurs in postmenopausal women by androgen secretion from adrenal or ovarian tumors. Additionally, the rising incidences of bodily disorders due to the presence of excessive body hair in women can cause cosmetic and psychological problems, which, in turn, is favoring the market growth. Moreover, healthcare professionals and activists are sensitizing the masses about available treatments for hirsutism, which is acting as another growth-inducing factor. Apart from this, the increasing demand for hair removal procedures with lasers and intense pulsed light (IPL) equipment requiring multiple treatment sessions is providing an impetus to the market growth. In line with this, manufacturers are focusing on developing topical metformin-based therapeutics that act as an effective treatment for moderate to severe hirsutism in women with PCOS, which is propelling the market growth. Furthermore, the increasing personal care expenditure due to the growing working women population is positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, growing acceptance of laser hair removal techniques, and the increasing prevalence of PCOS, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hirsutism market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapy type, products and end user.
Procedures
Medication
Hair Removal Equipment
Topical Hair Removal Products
Others
Hospitals
Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alma Lasers Ltd (Sisram Medical Ltd), Alpaya Dermaceuticals, Bayer AG, Cutera Inc., Cynosure Inc., Lumenis Inc., Nisim International Inc. and Sciton Inc.